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Abstract
Objective: The goal of this study is to advance an approach to the assessment of the quality of
studies considered for inclusion in systematic reviews of the effects of social-care interventions.
Method: To achieve this objective, quality is defined in relation to the widely accepted validity
typology; prominent approaches to study quality assessment are evaluated as to their adequacy.
Results: Problems with these approaches are identified.
Conclusion: A formal, yet explicit, multidimensional approach to assessment grounded in
substantive issues relevant to the intervention and the broader context in which it is embedded is
promoted. Uncritical and exclusive use of indicators of study quality such as publication status,
reporting quality, and single summative quality scores are rejected.
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“Scientific evidence is commonly and properly greeted with objections, skepticism, and
doubt…[R]esponsible scientists are responsibly skeptical…This skepticism is itself scrutinized.
Skepticism must itself be justified, defended. One needs ‘grounds for doubt’” (Rosenbaum,
1995, pp. 9-10).

There is a pressing need for the identification of evidence-based practices and policies to
promote pro-social development and well-being and to ameliorate widespread psycho-social and
cultural problems such as substance use, crime, and educational failure. It is equally important to
identify practices that are ineffective or harmful, programs that work in some situations and not
others, and alternative approaches that have similar outcomes. This knowledge can enhance the
impact and value of social care and help policymakers, clinicians, and consumers make informed
choices.
The identification of an efficacious and effective intervention requires a synthesis of
results of empirical investigations of the intervention. Traditional, narrative reviews of research
are vulnerable to well-documented biases (Bushman & Wells, 2001; Littell, 2008) that can be
countered by systematic reviews. These biases are not corrected by meta-analysis alone (Littell,
Corcoran, & Pillai, 2008; Petticrew & Roberts, 2006). A systematic review requires investigators
to identify studies of sufficient quality to include in the analysis (Juni, Altman, & Egger, 2001);
because, “if the ‘raw material’ is flawed, then the conclusions of systematic reviews cannot be
trusted” (Juni, Altman, & Egger, 2001, p. 42). Study quality assessment is also used in
systematic reviews to examine variation in the quality of included studies (Aos, Phipps,
Barnoski, & Lieb, 2001: Brestan & Eyberg, 1998; Cooper & Hedges, 1994); because variability
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in the quality of included studies may account for as much variability in the results of a
systematic review as intervention characteristics (Wilson & Lipsey, 2001).
Scholars agree that the quality of intervention studies varies; however, they disagree as to
how to conceptualize and measure study quality (Cooper, 1998; Petticrew & Roberts, 2006).
Despite the close to 300 measures of study quality that are available, there is no agreement as to
which one is best suited for evaluation of intervention studies (Deeks et al., 2003; Moher et al.,
1995; West et al., 2002). Moreover, empirical investigations show that when differing
assessment tools are used to evaluate the same study, they yield divergent findings (Herbison,
Hay-Smith, & Gillespie, 2006; Juni et al., 1999). This situation weakens the confidence the
public may place in the quality assessment and in the findings of any one review.
The number (and the prestige) of groups that have considered how to conceptualize and
to measure the quality of studies is one index of the significance and complexity of the issue.
The groups include international organizations such as the Cochrane Collaboration (Higgins &
Green, 2006) and the Campbell Collaboration (Shadish & Myers, 2004); professional societies,
such as the Society for Prevention Research (Flay, Biglan, Boruch, Castro, Gottfredson, Kellam,
et al., 2005); and governmental agencies, including the U.S. Centers for Disease Control (Zaza,
Briss & Harris, 2005), the U.S. Department of Education’s What Works Clearinghouse (U. S.
Department of Education, 2006), the U.S. Agency for Healthcare Research Quality (AHRQ;
West et al., 2002), the U.S. Department of Health and Human Services (DHHS) Substance
Abuse and Mental Health Services Administration (SAMHSA) (specifically, the National
Registry of Evidence-Based Programs and Practices) (U. S. Department of Health and Human
Services, nd); and the United Kingdom National Health Service (NHS) Health Technology
Assessment Programme (Deeks et al., 2003; Sutton, Abrams, Jones, Sheldon, & Song, 1998).
Yet, none of these groups has resolved definitively how to conceptualize or to measure the
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quality of studies to be included in systematic reviews.
Three major reviews of study quality assessment instruments have been completed within
the past 12 years. The earliest review was completed by David Moher and his colleagues
(Moher et al., 1995). The review’s purpose was to evaluate the instruments used to assess the
quality of randomized controlled trials of health-care interventions. The second review was
completed by Suzanne West and her colleagues (West et al., 2002). With support from the U. S.
Agency for Healthcare Research Quality, the review’s purpose was to identify measures that
were “high performing”. The third review was completed by Jonathan Deeks and his colleagues
(Deeks et al., 2003). One of the review’s purposes was to evaluate tools that could be used to
rate the quality of non-randomized studies of treatment effects (i.e., non-experimental and quasiexperimental designs). Taken together, the reviews show that most study quality assessment
tools have not been developed or tested using standard scale development techniques and
information is lacking, not surprisingly, on the validity and reliability of these scales.
Purposes and Scope of this Article
Our goal is not to provide a detailed review of measurement tools (see Deeks et al., 2003;
Moher et al., 1995; West et al., 2002 for work of this type) but, rather, to review and to evaluate
broad approaches to study quality assessment and to advocate one for use in systematic reviews.
Our discussion is framed primarily in relation to how reviewers might best decide to include or
exclude a given study in a systematic review, but we also comment on how reviewers might
reflect variation in the quality of included studies.
We focus on intervention research. Intervention studies seek to identify outcomes that
can be attributed to an intervention under ideal (efficacy studies) or “real world” conditions
(effectiveness studies). In this work, investigators aim to develop plausible, causal inferences
about an intervention’s effects.
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We refer to the health-care as well as to the social-care literature because much of the
discussion of study-quality assessment has occurred within the health-care field, and because the
interventions for health care and social care have converged in specific areas of practice (e.g.,
substance use, mental health, child welfare, and aging). Moreover, the central methodological
issues in systematic reviews are identical in both (see, for example, Hawe, Shiell, & Riley,
2004).
To achieve our purpose, we first describe broad approaches to assessing the quality of
empirical studies of intervention effects and examine their potential for use in evaluating primary
studies for inclusion in systematic reviews. Endorsing recent work in this area (Petticrew &
Roberts, 2006; Shadish, Cook, & Campbell, 2002), we then advocate one approach, the “risk of
bias” approach, to study quality assessment, for consideration and debate by scholars of
systematic review (Higgins & Green, 2006). In this approach, we define study quality primarily
in relation to a study’s internal validity or the strength of inferences one may draw as to an
intervention’s effects, although we also note how other types of validity – statistical conclusion
validity, construct validity, and external validity are relevant to the study quality assessment in
the context of systematic reviews.
Assessment Approaches
Publication Status
Historically, reviewers have used publication as an indicator of study quality. The
assumption has been that the peer-review process can be relied upon to guarantee “completeness
and accuracy of reporting, analyzing, and interpreting the study design and results” (Brestan &
Eyberg, 1998, p. 181).
This is often, but not always, the case. Despite the efforts of journal editors to
systematize the review process (for an example, one could refer to the review process for the

Study quality 7
journal, Child Abuse and Neglect), reviewers’ judgments of the same study may differ widely.
Thus, some published reports describe investigations of low quality, due to the vagaries of the
peer review process (Grayson, 2002). Some are insufficiently detailed so that it is not possible to
determine the quality of the investigations (Begg et al., 1996).
Moreover, there is evidence that publication decisions may be affected by factors other
than study quality and clarity of reporting. For example, scholars do not always evaluate
critically evidence that contradicts their views (Mahoney, 1997; Petticrew & Robers, 2006). As
a result, some low-quality studies are published and some high-quality reports do not enter the
public domain.
Publication status is also confounded with a bias toward specific types of findings. For
example, study reports that contain statistically significant results and those that confirm research
hypotheses are significantly more likely to be published than those with null or negative
findings, all other relevant factors being equal (Mahoney, 1997; Begg, 1994; Rothstein, Sutton,
& Bornstein, 2005). This bias is the result of actions taken by authors, reviewers, and editors of
journals (Dickersin, 2005): Authors are more likely to submit significant results for publication;
peer reviewers are more likely to recommend and journal editors are more likely to accept for
publication those reports that contain statistically significant results and to reject those that do
not (for reviews of empirical evidence of publication bias, see Dickersin, 2005; Song et al., 2000;
Sutton, 2005; Torgerson, 2006). Similarly, there is evidence of selective reporting of outcomes
in publications of randomized controlled trials, such that results that are not statistically
significant are reported inadequately or omitted altogether (Chan, Hrobjartsson, Haar, Gotzsche,
& Altman, 2004; Scherer, Langenberg, & von Elm, 2007). In short, publication processes may
introduce a systematic bias that tends to inflate estimates of intervention effects (Hopewell,
McDonald, Clarke, & Egger, 2006; Sutton, 2005).
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Following Hannah Rothstein and her colleagues (Rothstein, Sutton, & Bornstein, 2005),
the Cochrane Collaboration (Higgins & Green, 2006), and others (Moher et al., 2007; Shea et al.,
2007), we endorse the position that publication status should not be used to make the decision as
to whether an empirical investigation is included or excluded from a systematic review.
Reporting Quality
Reviewers may be tempted to use the completeness of a study report as an indicator of
the quality of the study. Several systems have been developed to assess the quality of reporting
on empirical investigations. Reporting guidelines include checklists of topics that must be
addressed and sample-flow diagrams that provide readers with the information needed to
appraise a study, assess its bias, and evaluate the extent to which its findings could be
generalized.
Reporting guidelines for primary research include the Consolidated Standards on
Reporting Trials (CONSORT; Begg et al. 1996; Moher, Schultz & Altman, 2001), Transparent
Reporting on Evaluations with Nonrandomized Controlled Trials (TREND; Caetano, 2004), and
Standards for Reporting of Studies of Diagnostic Accuracy (STARD; Bossuyt, Reitsma, Bruns,
Gatsonis, Glasziou, Irwig, et al., 2003). Guidelines for reporting systematic reviews and metaanalysis are also available (see Moher et al., 1999). Items considered essential for appraising the
quality of reporting on RCTs (Randomized Controlled Trials) (in the CONSORT statement)
differ from those required to appraise reporting on non-RCTs (in the TREND statement) and
diagnostic studies (in the STARD statement).
Although completeness and quality are often difficult to distinguish, one cannot stand for
the other. A high quality study might also be one that has been reported incompletely.
Therefore, reviewers should obtain information that is missing and should clarify information
that is confusing by contacting the investigators prior to evaluating the quality of their work.
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We conclude that while reporting guidelines might help reviewers to identify the
information that they need to obtain prior to conducting an evaluation of the quality of a study,
these guidelines should not be used to evaluate such quality.
Design Hierarchies
Several groups have proposed hierarchies of research designs that could be used to rank
studies of intervention effects in terms of their quality, typically defined as internal validity, as
the example displayed in Table 1 shows. In most design hierarchies, the randomized controlled
design is considered
--------------------------------Insert Table 1 about here
---------------------------------the most trustworthy design for efficacy and effectiveness studies, followed by non-randomized
comparison group designs that use parallel cohorts (preferably with some form of matching).
Observational studies, such as case-control studies and single-group designs are considered
weaker than parallel cohort studies (cf. Shadish, Cook & Campbell, 2002). Non-experimental
studies, including case studies, and expert opinion are usually placed at the bottom of evidence
hierarchies.
The rationale for these hierarchies appears to be twofold. There is some overlap between
overall research design and internal validity; that is, some designs tend to produce more credible
causal inferences than others. For example, well-executed RCTs provide better controls for
selection bias than other methods (Schultz, Chalmers, Hayes, & Altman, 1995). Second, there is
substantial evidence of “method effects;” that is, results of studies of intervention effects can be
greatly affected by research methods (Wilson & Lipsey, 2001). Results of RCTs are not
consistently approximated with other research designs (Glazerman, Levy, & Myers, 2002; Kunz,
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Vist, & Oxman, 2002).
The Maryland Scientific Methods Scale (MSMS), shown in Table 2, is one example of
this approach. We chose the MSMS to illustrate this approach because it has been used widely
in systematic reviews (c.f., Aos, Phipps, Barnowski, & Leib, 2001). This scale was developed
by Lawrence Sherman and his colleagues (Sherman et al., 1998) to assess the level of internal
-------------------------------Insert Table 2 about here
--------------------------------validity of evaluations of crime prevention programs. It is a single, ordinal scale comprised of
five categories. Each category corresponds to a type of research design and is associated with a
numerical score. The designs are ranked in terms of their ability to handle threats to internal
validity. Level 1 refers to a study that produces a correlation between a prevention program and a
measure of crime at one point in time. Such a study is considered to have the lowest internal
validity because "the design fails to rule out many threats to internal validity and also fails to
establish causal order (Sherman et al., 1998, p. 16)." Level 5 refers to a study that uses a
randomized controlled trial. Such a study is considered to have the highest level of internal
validity because nearly all threats to the internal validity of the study can be eliminated. The
scale can be used to rate study quality in conjunction with four additional questions, three of
which focus on statistical conclusion validity and one of which focuses on construct validity
(Farrington, Gottfredson, Sherman, & Welsh, 2002).
The design hierarchy approach to study quality assessment has the advantage of
simplicity. However, it does not account for sources of bias that may compromise the internal
validity of a randomized controlled trial or other research designs. For example, important
sources of bias or threats to the internal validity of a study include selection bias, or differences
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between study groups other than exposure to the treatments under investigation, and attrition, or
systematic differences between groups in withdrawal from treatment or from outcome
assessment. (Whenever drop-outs differ from those who remain in treatment, the latter are no
longer representative of the initial treatment group. The comparability of groups is further
diminished when participants who withdraw from one group are different from those who
withdraw from another (differential attrition). This limits the ability to detect differences that are
due to treatment.). Of the two, selection bias is probably the most important threat to internal
validity in intervention research (Larzelere, Kuhn, & Johnson, 2004; Higgins & Green, 2006;
Shadish, Cook, & Campbell, 2002). Schultz and colleagues (Schultz & Grimes, 2002; Shultz,
Chalmers, Hayes, & Altman, 1995) have shown that even randomized controlled trials do not
always protect against selection bias. Moreover, because validity is a property of the inferences
that can be drawn from empirical results, neither a property of research designs nor of methods
(Shadish et al., 2002), we argue the design hierarchy approach to study quality assessment
should not be employed by itself.
Design Features
Scholars have focused on features of study design and implementation that could be
linked to study quality. Some emphasize specific features sought in randomized controlled trials
(c.f., Chalmers et al., 1981). For example, instead of simply classifying a study as a RCT, an
analyst might assess how random allocation was generated (for example, a toss of a coin, use of
a random numbers table, or reliance on a computer-generated random assignment procedure),
whether and how allocation was concealed until after participants enrolled in the study, how
recruitment and enrollment took place, or how much attrition occurred in each group at specific
points in time.
The Methodological Quality Rating Scale (MQRS), as shown in Table 3, was developed
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by William Miller and his colleagues. It is designed to evaluate "the methodological quality of
clinical trials in the alcohol field” (Miller & Wilbourne, 2002, p. 266), defined implicitly in
relation to the relative absence of threats to the internal validity of a study
-------------------------------Insert Table 3 about here
--------------------------------The MQRS is intended for use with studies in which there is at least one treatment group, a
comparison condition, a sampling procedure intended to produce equivalent groups before
treatment, and an outcome measure.
The MQRS is comprised of 12 items, with each one reflecting a unique aspect of study
quality. An item has two or more response categories. Each response is assigned a number, with
lower numbers reflecting lower quality, and these numbers are added to produce a total
methodological quality score. The coding manual for the scale is available on the web
(www.casaa.unm.edu). The total scale score ranges from 0 to 17. A study that receives a total
score of 14 (or higher) is considered a well-designed study (Miller, Andrews, Wilbourne, &
Bennet, 1998; Miller & Wilbourne, 2002).
We argue that uncritical use of total scale scores in this and other similar scales is
problematic because many of the subscales or components of study quality scales appear to be
orthogonal. A single summary score may represent therefore very different qualities and not be
particularly meaningful.
Nonetheless, the strategy used by William Miller and his colleagues has several
advantages over a priori judgments about overall research design---a major one being that it
produces more complete (and possibly more objective) information about the conduct of a study
(Cooper, 1998). Instruments that capture features of study design may help reviewers to assess
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plausible sources of bias in a particular study and to make competent judgements as to whether a
study is of sufficient quality to be included in a systematic review.
The Validity Framework
Scholars have also equated study quality with the relative absence of threats to the
validity of an intervention study. In this framework, validity may be restricted to internal
validity, that is the strength of inferences that may be drawn regarding hypothesized causal
relationships (Campbell & Stanley, 1966; Cook & Campbell, 1979; Shadish et al., 2002), or it
may also include the strength of inferences that may be drawn regarding external validity,
construct validity, and statistical conclusion validity (c.f., Downs & Black, 1998).
The Quality Index (Downs & Black, 1998), shown in Table 4, is one well-regarded
example of this later approach (Deeks et al., 2003; West et al., 2002). The QI is a 27-item
checklist designed for use with both randomized controlled trials and observational studies. The
index is comprised of the following five subscales (with the number of items comprising each
one contained in parentheses): Reporting (10), External (3), Internal Validity – Control of Bias
--------------------------------Insert Table 4 about here
--------------------------------(7); Validity Internal Validity – Confounding (6); and Power (1). Depending on the subscale, the
rater indicates whether the item should be checked as “yes”, “no”, or “unable to determine”.
Each item is stated positively; that is, it represents a desired design or reporting feature of
randomized controlled trials. Responses can be scored and summed to produce subscales as well
as a total score, with higher scores indicating higher quality.
As noted above, the use of a single total score to make the decision as to whether a study
should be included in a systematic review, as is possible with the Quality Index, is problematic.
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However, the use of the QI or other subscales that assess threats to differing types of validity
may well help reviewers to evaluate the quality of studies to include in systematic reviews.
The Risk of Bias Framework
Despite the utility of some of the approaches to study quality assessment we describe
above, we concur with scholars of research synthesis (Cooper, 1998; Wortman, 1994) that the
ideal approach to study quality assessment is one that encourages reviewers to assess features of
a study’s design in order to assess the risk of bias or threats to the validity of a study.
While scales might be useful in this approach, the emphasis is on the questions reviewers
must pose in order to assess competently the major sources of bias that are of greatest concern in
studies of intervention effects (Higgins & Green, 2006). These are selection bias and attrition
bias which constitute threats to internal validity and performance and detection bias which
constitute threats to construct validity. Selection bias refers to systematic differences between
study groups other than exposure to the treatments under investigation; attrition bias refers to
systematic differences between groups in withdrawal from treatment or from outcome
assessment; performance bias refers to systematic differences in the care provided to groups
other than the treatments under investigation; and detection bias refers to systematic differences
between groups in the assessment or reporting of outcomes. Based on the reviewers’ judgments
of these risks, studies are included or excluded from inclusion in a systematic review.
To aid in this process, scholars have sought empirical evidence about sources of bias and
about the effectiveness of ways to reduce bias in studies of intervention effects. For example,
investigations show that if group allocation can be foreseen or altered by researchers, clinicians,
or participants, selection biases are likely to limit the comparability of groups (Schultz &
Grimes, 2002). Other design features that have been linked empirically to biased results include
procedures for assessing outcome that are not “blind” to group assignment, differential loss of
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participants from intervention and control or comparison groups, and the exclusion of data from
participants who drop-out of the study prior to its completion from outcome analyses (Schultz et
al., 1995).
The approach to study quality taken by the Cochrane Collaboration, the international
organization that produces and distributes systematic reviews in health care, provides one
prominent example of a “risk of bias” approach to study quality assessment. The Cochrane
Handbook for Systematic Reviews of Interventions (Higgins & Green, 2006) describes an
approach to quality assessment that focuses on validity of inferences, explicit descriptions of
study design and implementation characteristics, and empirical evidence of bias in studies of
interventions effects (Higgins & Green, 2006). Cochrane reviewers are encouraged to extract
carefully data on multiple study features, using inter-rater reliability checks to ensure accuracy.
They then consider several potential sources of bias.
Of particular concern is the presence of selection bias. Given empirical evidence that
allocation methods and allocation concealment relate to selection bias (Schultz et al., 1995;
Schultz & Grimes, 2002), relevant questions for assessment of selection bias are as follows: Was
the method of allocation random (unpredictable)? Was the method of allocation blind (concealed
until after enrollment)? Reviewers rate the quality of allocation concealment as “adequate”,
“unclear”, “inadequate”, or “not used”.
Cochrane reviewers are also encouraged to rate performance bias, attrition bias, and
detection bias. Relevant questions for detection bias, for example, are: Who assessed outcomes?
Were assessors blind to the treatment condition? Were results reported selectively or for all
outcomes measured?
There are several ways to use these guidelines (Higgins & Green, 2006). Reviewers can
identify specific criteria for each type of bias and rate whether all, some, or none of the criteria in
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each domain were met. They can (and do) draw on existing study quality assessment devices to
aid in this process.
In short, the Cochrane guidelines, building on a risk of bias framework, advocate a multidimensional yet flexible approach to study quality assessment. The approach taken represents an
advance over an assessment of designs, design features, or the validity framework alone, and it
emphasizes the critical role of reviewers’ judgments in the study-quality-assessment process.
This may be particularly important in some fields of practice where specific features of the
problem for which an intervention is designed have implications for how best to investigate the
efficacy or effectiveness of the intervention.
The Cochrane Collaboration approach has been adopted by the international Campbell
Collaboration (C2) (www.campbellcollaboration.org), and it has been applied to systematic
reviews of social, educational, and criminological interventions (Boruch, Petrosino, & Chalmers,
1999). C2, as does the Cochrane Collaboration, encourages reviewers to analyze carefully study
design and implementation qualities and to assess risk of bias, paying attention to the particular
conceptual, contextual, and methodological issues that arise in the empirical investigations under
review. It emphasizes the importance of multi-dimensional approaches to quality assessment of
intervention studies, the delineation of specific study features, and the use of empirical methods
to explore how these features may influence conclusions of a review (Shadish & Myers, 2004).
Not surprisingly, C2 discourages the use of scales and indices that produce a single score to
judge study quality (Shadish & Myers, 2004), as does the Cochrane Collaboration (Higgins &
Green, 2006). Thus, the approach is flexible yet rigorous, emphasizing a pragmatic rather than a
uniform approach to study quality assessment (Morgan, 2007).
Additional Observations: Study Quality Assessment in Systematic Reviews
Tailoring Quality Assessment to Broad Study Purpose
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Indeed, it would strengthen the practice of systematic reviews and, by implication the
assessment of the quality of studies to be included in such reviews, if it were made clear at the
outset whether the review was to examine the efficacy or the effectiveness of an intervention.
Although one might argue that the two types are not distinct, but that they exist on a continuum,
the questions one would ask to assess the quality of efficacy and the quality of effectiveness
studies clearly differ.
The Agency for Healthcare Research and Quality (Gartlehner et al., 2006) recently
proposed seven domains that could be examined in order to distinguish the two study types:
population under study, eligibility criteria, outcomes of interest, duration of follow-up period,
adverse events, sample size, and intention-to-treat analysis. They argue that effectiveness
studies, in partial contrast to efficacy studies, should include “a diverse population with the
condition of interest” (p. 6); should involve “eligibility criteria .. [to] allow the source population
to reflect the heterogeneity of the…population” (p. 6); should include “health outcomes, relevant
to the condition of interest” (p. 7); should be of sufficient duration in order to “mimic a minimum
length of treatment in a clinical setting” (p. 7); should assess adverse events identified in efficacy
trials; should include a sample size of sufficient power to “assess a minimally important
difference from a patient perspective” (p. 7); and should include the data for all subjects enrolled
initially in the study in the analysis.
Casting Inclusion Criteria
Clarification as to whether a review is to focus on efficacy or effectiveness helps
reviewers to identify explicit a priori eligibility criteria that studies must meet in order to be
included in the review. Using the popular “PICO” framework, reviewers determine which
populations, interventions, comparisons, and outcomes will be included and excluded in a review
(Higgins & Green, 2006). These issues relate to the external and construct validity of a review,
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and guide the search for and identification of relevant studies. In our view, decisions abut the
scope and boundaries of a review should be driven by its central questions and objectives.
With clear objectives in mind, reviews of intervention effects must contend with concerns
about internal validity. Reviewers must decide which overall study designs and/or
methodological features are critical to support credible inferences about intervention effects.
Reviewers cast inclusion criteria in differing ways. Some limit systematic reviews of
intervention effects to RCTs, whereas others include observational studies such as those that
depend on cohort or case-control designs. Some reviewers limit included studies to those with
specific design features thought to be essential in a particular context (e.g., blinded assessment,
low attrition, and/or intention-to-treat analysis). These choices vary, depending in part on the
plausible threats to validity and nature of available research in different fields of practices,
cultures, and geopolitical contexts.
Regarding statistical conclusion validity, it is important to note that systematic reviews in
general, and meta-analysis in particular, can overcome some problems that occur in primary
studies that lack sufficient statistical power and/or appropriate statistical analyses. Although
these issues (power and analysis) are important for critical appraisal of primary studies of
intervention effects, they should not constitute initial barriers to inclusion in systematic reviews.
Assessing Variation in Methodological Quality
Irrespective of how investigators cast the inclusion criteria, inevitably there will be
variations in design features among studies included in a systematic review. These variations are
often considered possible explanations for heterogeneity of effects among studies (Lipsey &
Wilson, 2001). As mentioned above, methodological characteristics can account for substantial
portions of the variance in effect sizes (Lipsey & Wilson, 2001).
Study qualities are captured during the data extraction phase of a review, by rating or
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ranking studies according to pre-specified methodological characteristics. Several study quality
assessment instruments could be used for this purpose. Since there is no agreed-upon standard,
reviewers have considerable latitude to select and adapt devices for this purpose. Doubleextraction and coding of data from primary studies, assessment of inter-rater agreement, and the
development of consensus ratings is considered best practice (Higgins & Green, 2006; Littell,
Corcoran, & Pillai, 2008). Reviewers should provide a descriptive analysis of variations in study
qualities. Many Cochrane and Campbell reviews include a table of study qualities (e.g.,
Smedslund et al., 2006).
Despite the field’s move toward a multi-dimensional approach to study quality
assessment, some reviewers have used overall quality scores to weight results of studies in metaanalysis (e.g., Aos et al., 2001). There is little support, however, for this approach and metaanalysts have argued that the use of overall quality scores in meta-analysis should be abandoned
(Herbison et al., 2006). Instead, most meta-analysts use individual items that represent design
features or risk of bias in sensitivity and moderator analyses (for examples, see Smedslund et al.,
2006; Shadish & Baldwin, 2005; Wilson, MacKenzie & Mitchell, 2005)
Discussion and Applications to Social Work
Use of a multi-dimensional approach to study quality assessment will advance the science
of systematic reviews of health-care and social-care interventions including those directly
relevant to social work or to social welfare programs.
A systematic review of welfare-to-work programs conducted by a Norweigan team is an
exemplar of the multidimensional approach (Smedslund, et al., 2006). In order to assess the
quality of a study, two members of the team evaluated independently the study’s characteristics,
design, participants, and interventions in order to determine whether or not the study contained
an adequate approach to randomization sequence, concealment of randomization sequence,
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prevention of performance bias, prevention of detection bias, and attrition bias, and whether the
study’s investigators had conducted an intent-to-treat analysis. Raters resolved disagreements in
ratings through discussion and consultation with a third reviewer, if needed.
Based on meta- and moderator- analyses of study data, the team concluded their report
with a nuanced discussion of the status of randomized controlled studies of welfare-to-work
programs within the United States in contrast to those in other industrialized nations; the
reliability of administrative data typically used in the investigations under study; the robustness
of the effects found in light of the relative absence of knowledge of the extent to which increases
in income from work offset decreases in income from welfare payments; the extent to which
findings may be generalized to societies outside the United States; and the difficulty of
determining whether welfare-to-work programs are voluntary or mandatory and, hence,
understanding whether one approach or the other is more effective. (They might have added
further caveats reflecting the variability in welfare-to-work programs within the United States.)
Thus, reviewers thought critically and carefully about the strengths and limitations of the
welfare-to-work studies they identified. They concluded with a commitment to reevaluate the
review every two years thereby showing one way in which science is an ongoing process and
systematic reviews, rather than providing the “last word” on a topic, contribute to a continuing
dialogue among the community of scholars concerned with a social welfare problem. Systematic
reviews can contribute to debates about the importance of methodological features and
intervention characteristics; they can identify anomalies in a body of research that may challenge
shared beliefs.
In conclusion, efforts to standardize the definition of study quality, to treat it as a unidimensional construct amenable to scale development, or to reduce its assessment to simple
procedures are unlikely to be successful. Assessment of study quality must be integrated into the
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work of practitioners of science. It requires publicly available data-bases, full and complete
scientific reports, transparent study quality assessment reports, and dialogue and empirical study
as to how to evaluate the quality of evidence. These are essential components of a credible
evidence-base for policy and practice.
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Table 1: A design hierarchy
Systematic review and meta-analysis of randomized controlled trials
Randomized controlled trials
Non-randomized parallel cohort studies
Observational studies
Non-experimental studies
Expert opinion
Adapted from Harbour & Miller (2001).
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Table 2: Maryland Scientific Methods Scale (Sherman et al., 1998)
Level

Requirement

5

Random assignment of program and control conditions to units

4

Dependent measures obtained before and after the intervention in multiple
experimental and control units, controlling for other variables that influence outcomes

3

Dependent measures obtained before and after the intervention in experimental and
comparable control conditions

2

Dependent measures obtained before and after the intervention, with no comparable
control conditions

1

Correlation between an intervention and a dependent measure at one point in time
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Table 3: Methodological Quality Rating Scale (MQRS; Miller & Wilbourne, 2002)
Group
allocation

4 = Randomization
3 = Within S counterbalanced
2 = Case control / matching
1 = Quasi-experimental design, arbitrary assignment, sequential cohorts
0 = Violated randomization or nonequivalent groups

Quality
control

1 = Treatment standardized by manual, specific training, content coding, etc.
0 = No standardization of treatment specified

Follow-up
rate

2 = 85-100% follow-ups complete
1 = 70-84.9% follow-ups complete
0 = <70% follow-ups complete or longest follow-up < 3 months

Follow-up
length

2 = 12 months or longer
1 = 6-11 months
0 = Less than 6 months or unspecified

Contact

1 = Personal or telephone contact for at least 70% of completed follow-ups
0 = Questionnaire, unspecified, or completed < 70% of cases

Collaterals

1 = Collaterals interviewed in > 50% of cases
0 = No collateral verification in most cases or unspecified

Objective

1 = Objective verification (records, serum, breath) in > 50% cases
0 = No objective verification in most cases or unspecified

Dropout

Applies to cases that dropped out of treatment after randomization or treatment
assignment
1 = Treatment drop-outs are clearly enumerated and/or characteristics of dropouts are compared with those for completed cases on baseline characteristics
0 = Treatment drop-outs are not reported, or all non-completers were excluded
from outcome analyses

Attrition

Applies to cases lost to follow-up after completion of treatment
1 = Cases lost to follow-up are enumerated and (a) considered in outcome in
analyses at some follow-up points, (b) outcomes are imputed for lost cases
and included in analyses, or (c) characteristics of lost cases are found to be
comparable with those for retained cases at baseline or a prior follow-up
point
0 = Cases lost to follow-up are not considered in outcome analyses

Independent

1 = Follow-up conducted by independent interviewers blind to group
0 = Follow-up by nonblind, unspecified, or questionnaire data only
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Analyses

1 = Acceptable statistical analyses of group differences
0 = No statistical analysis, inappropriate, or unspecified

Multisite

1 = Parallel replication at 2 or more sites with separate research teams
0 = Single site study or comparison of sites offering different treatments

Study quality 34
Table 4: Quality Index (Downs & Black, 1998, pp. 382-383)
Reporting: Were the following clearly described? (Y/N)
1. Study hypothesis/aim/objective
2. Main outcomes
3. Characteristics of the participants
4. Interventions of interest
5. Distributions of principal confounders in each group
6. Main findings
7. Estimates of random variability for main outcomes
8. All the important adverse events that may be a consequence of intervention
9. Characteristics of patients lost to follow-up
10. Actual probability values for main outcomes
External validity (Y/N/unable to determine)
11. Were subjects who were asked to participate representative of the entire population from
which they were recruited?
12. Were subjects who were prepared to participate representative of the entire population from
which they were recruited?
13. Were the staff, places, and facilities representative of the treatment the majority of subjects
received?
Internal validity – bias (Y/N/unable to determine)
14. Was an attempt made to blind subjects to the intervention they received?
15. Was an attempt made to blind those measuring main outcomes of the intervention?
16. If any of the results of the study were based on “data dredging” was this made clear?
17. In trials and cohort studies, do analyses adjust for different lengths of follow-up? Or, in
case-control studies, is the period between intervention and outcome the same for cases and
controls?
18. Were appropriate statistical tests used to assess the main outcomes?
19. Was compliance with the intervention reliable?
20. Were main outcome measures reliable and valid?
Internal validity – confounding (selection bias) (Y/N/unable to determine)
21. For trials and cohort studies, were patients in different intervention groups? For case-control
studies, were cases and controls recruited from the same population?
22. For trials and cohort studies, were subjects in different intervention groups? For casecontrol studies, were cases and controls recruited over the same period of time?
23. Were subjects randomized to intervention groups?
24. Was the randomized intervention assignment concealed from both patients and staff until
recruitment was complete and irrevocable?
25. Was there adequate adjustment for confounding in the analyses from which main findings
were drawn?
26. Were losses of subjects to follow-up taken into account?
Power
27. Did the study have sufficient power to detect a clinically important effect where the
probability for a difference due to chance was less than 5%?
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